Astera Labs (NASDAQ:ALAB) Shares Down 3.7% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB) fell 3.7% on Monday. The company traded as low as $342.00 and last traded at $351.31. Approximately 4,064,165 shares changed hands during mid-day trading, a decline of 22% from the average daily volume of 5,230,728 shares. The stock had previously closed at $364.62.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Citigroup reiterated a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Barclays upped their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research report on Monday, July 20th. Susquehanna increased their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Finally, Roth Capital reissued a “buy” rating and issued a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $348.33.

Astera Labs Stock Down 3.7%

The firm has a market cap of $60.95 billion, a price-to-earnings ratio of 173.92 and a beta of 3.77. The company’s fifty day moving average is $305.17 and its 200 day moving average is $274.90.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period in the previous year, the business earned $0.44 EPS. The company’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the transaction, the general counsel owned 96,542 shares in the company, valued at $32,872,551. This trade represents a 6.58% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $311.83, for a total value of $2,804,599.02. Following the completion of the sale, the director directly owned 3,970 shares in the company, valued at approximately $1,237,965.10. This represents a 69.38% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 591,558 shares of company stock worth $209,458,976. Corporate insiders own 10.40% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Keating Financial Advisory Services Inc. acquired a new position in shares of Astera Labs during the 2nd quarter worth approximately $25,000. Archer Investment Corp acquired a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $30,000. Transamerica Financial Advisors LLC acquired a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $35,000. Continuum Advisory LLC bought a new position in shares of Astera Labs in the second quarter valued at $37,000. Finally, Johnson Financial Group Inc. acquired a new position in Astera Labs during the second quarter worth $43,000. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data-center operators, system manufacturers and other customers connect, expand and manage the high-speed components used in servers, storage systems and networking platforms.

The company’s portfolio includes PCI Express (PCIe) retimers and fabric switches, Compute Express Link (CXL) memory connectivity products, and Ethernet connectivity solutions.